Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia.
Storb
R
R
Pepe
M
M
Deeg
H J
HJ
Anasetti
C
C
Appelbaum
F R
FR
Bensinger
W
W
Buckner
C D
CD
Cliff
R A
RA
Doney
K
K
Hansen
J
J
D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006086:Graft vs Host Disease / Q000517:prevention & control*; D006680:HLA Antigens / Q000032:analysis; D006650:Histocompatibility Testing; D006801:Humans; D007938:Leukemia / Q000601:surgery*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000601:surgery*; D015470:Leukemia, Myeloid, Acute / Q000601:surgery*; D008727:Methotrexate / Q000627:therapeutic use*; D013997:Time Factors
D006680:HLA Antigens; D016572:Cyclosporine; D008727:Methotrexate